Product Information
TADALAFIL 2.5 MG TABLET is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $0.1127 per EA under NDC 13668056530. Its NADAC has been published 387 times since May 8, 2019.
FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Torrent Pharmaceuticals LimitedNDC
13668056530
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA211839FDA Approved
3/26/2019
TE Code
AB1
On Market Since
3/26/2019
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 2.5 MG TABLET has been published 387 times since May 8, 2019, and over the history we have for it it has declined 98.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1127 per EA |
|---|---|
| All-time high | $7.6664 (Jun 12, 2019) |
| All-time low | $0.0828 (Jul 17, 2024) |
| 52-week high | $0.1262 |
| 52-week low | $0.1127 |
| Median price | $0.1697 |
| Average price | $0.2997 |
| Largest weekly change | -96.2% (Jun 19, 2019) |
| Weeks tracked | 387 |
| Tracking since | May 8, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TADALAFIL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Torrent Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TADALAFIL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TADALAFIL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 2.5 MG TABLET, manufactured by Torrent Pharmaceuticals Limited, is $0.1127 per EA (NDC 13668056530), effective Sep 30, 2026.
How has the price of TADALAFIL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 2.5 MG TABLET has declined 98.5%. It has been tracked across 387 weekly CMS publications since May 8, 2019.
What are the highest and lowest recorded NADAC prices for TADALAFIL 2.5 MG TABLET?
Since May 8, 2019, the NADAC for TADALAFIL 2.5 MG TABLET has ranged from a low of $0.0828 (Jul 17, 2024) to a high of $7.6664 (Jun 12, 2019), with a median of $0.1697 per EA.
Are there cheaper alternatives to TADALAFIL 2.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TADALAFIL 2.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TADALAFIL 2.5 MG TABLET?
TADALAFIL 2.5 MG TABLET (NDC 13668056530) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.